Beneficial effect of growth hormone on severe delay in motor development in a child with down syndrome

2Citations
Citations of this article
7Readers
Mendeley users who have this article in their library.

Abstract

We administered recombinant human growth hormone (r-hGH) to a 4-year and 3-month old girl with Down syndrome who had a severe delay in motor development as well as short stature in an attempt to induce acceleration of motor development. She measured 91.5 cm (-2.61 SD) and weighed 13.4 kg. She had pervasive developmental delay without acquisition of language or the ability to sit up. There was improvement in her growth rate after r-hGH administration. She was capable of walking by herself after 5 months of r-hGH therapy. Eleven months after the initiation of treatment, the patient (5 years and 1 month) measured 97.8 cm (-2.43 SD) and weighed 15.2 kg. The protein anabolic activity of GH seems to have improved muscle strength and motor ability leading to improvement of her quality of life. This suggests that r-hGH therapy may be a beneficial treatment for children with Down syndrome. Copyright© 2001 by The Japanese Society for Pediatric Endocrinology.

Cite

CITATION STYLE

APA

Yasuhara, A., & Yoshida, Y. (2001). Beneficial effect of growth hormone on severe delay in motor development in a child with down syndrome. Clinical Pediatric Endocrinology, 10(2), 137–140. https://doi.org/10.1297/cpe.10.137

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free